Name: Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall (en Inglés)
Price: 64.84 USD
Availability: InStock
Author: Qi Jiang (Editor), H. Amy Xia (Editor)
ISBN: 9780367576004

portada Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall (en Inglés)

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall (en Inglés)

Formato

Libro Físico

Editorial

Crc Pr Inc

Autor

Qi Jiang (Editor), H. Amy Xia (Editor)

Idioma

Inglés

N° páginas

382

Encuadernación

Tapa Blanda

ISBN13

9780367576004

N° edición

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall (en Inglés)

Qi Jiang (Editor), H. Amy Xia (Editor) (Autor) · Crc Pr Inc · Tapa Blanda

Libro Nuevo Importado

Envío: 22 a 29 días háb.

$ 117.90$ 64.84

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 30 unidades

$ 64.84

Llega entre el 17 Ago y el 28 Ago a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall (en Inglés)"

State-of-the-Art Methods for Drug Safety AssessmentResponding to the increased scrutiny of drug safety in recent years, Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting explains design, monitoring, analysis, and reporting issues for both clinical trials and observational studies in biopharmaceutical product development. It presents the latest statistical methods for drug safety assessment. The book's three sections focus on study design, safety monitoring, and data evaluation/analysis. The book addresses key challenges across regulatory agencies, industry, and academia. It discusses quantitative approaches to safety evaluation and risk management in drug development, covering Bayesian methods, effective safety graphics, and risk-benefit evaluation.Written by a team of experienced leaders, this book brings the most advanced knowledge and statistical methods of drug safety to the statistical, clinical, and safety community. It shares best practices and stimulates further research and methodology development in the drug safety area.